Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

The role of point mutations in the genes, predisposing inherited thrombophilia in the pathogeneses of proximal and distal deep vein thrombosis in Georgian population.

Pirtskhelani N, Kochiashvili N, Makhaldiani L, Pargalava N, Gaprindashvili E, Kartvelishvili K.

Georgian Med News. 2014 Feb;(227):98-102.

PMID:
24632657
2.

Impact of inherited thrombophilia on the risk of recurrent venous thromboembolism onset in Georgian population.

Pirtskhelani N, Kochiashvili N, Makhaldiani L, Pargalava N, Gaprindashvili E, Kartvelishvili K.

Georgian Med News. 2014 Feb;(227):93-7.

PMID:
24632656
3.

Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?

Kreidy R, Irani-Hakime N.

Vasc Health Risk Manag. 2009;5:627-33. Epub 2009 Aug 6.

4.

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.

N Engl J Med. 1999 Sep 9;341(11):801-6.

5.

Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis.

Larsen TB, Nørgaard-Pedersen B, Lundemose JB, Rüdiger N, Gaustadnes M, Brandslund I.

Thromb Res. 2000 May 15;98(4):233-9.

PMID:
10822069
6.

[Genetic determinants of hereditary thrombophilia in pathogenesis of venous thrombosis].

Kapustin SI, Blinov MN, Kargin VD, Filanovskaia LI, Saltykova NB, Beliazo OE, Golovina OG, Shmeleva VM, Panshina AM, Papaian LP.

Ter Arkh. 2003;75(10):78-80. Russian.

PMID:
14669613
8.

Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.

Martinelli I, Battaglioli T, Razzari C, Mannucci PM.

J Thromb Haemost. 2007 Jan;5(1):98-101. Epub 2006 Oct 25.

9.

The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.

Al-Allawi NA, Badi AI, Goran MA, Nerweyi FF, Ballo HM, Al-Mzury NT.

Genet Test Mol Biomarkers. 2015 Sep;19(9):500-4. doi: 10.1089/gtmb.2015.0099. Epub 2015 Jul 21.

PMID:
26196588
10.

Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.

Wahba MA, Ismail MA, Saad AA, Habashy DM, Hafeez ZM, Boshnak NH.

Blood Coagul Fibrinolysis. 2015 Apr;26(3):309-15. doi: 10.1097/MBC.0000000000000242.

PMID:
25565385
11.

Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.

Kovac M, Mitic G, Mikovic Z, Antonijevic N, Djordjevic V, Mikovic D, Mandic V, Rakicevic L, Radojkovic D.

Clin Appl Thromb Hemost. 2010 Feb;16(1):66-70. doi: 10.1177/1076029608320721. Epub 2008 Sep 15.

PMID:
18796457
12.

Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.

González-Porras JR, García-Sanz R, Alberca I, López ML, Balanzategui A, Gutierrez O, Lozano F, San Miguel J.

Blood Coagul Fibrinolysis. 2006 Jan;17(1):23-8.

PMID:
16607075
13.

A Study on Hereditary Thrombophilia and Stroke in a Cohort from Sri Lanka.

Kalpage HA, Sumathipala DS, Goonasekara HW, Dissanayake VH.

J Stroke Cerebrovasc Dis. 2016 Jan;25(1):102-9. doi: 10.1016/j.jstrokecerebrovasdis.2015.08.042. Epub 2015 Oct 27.

PMID:
26522268
14.

Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.

De Stefano V, Casorelli I, Rossi E, Zappacosta B, Leone G.

Semin Thromb Hemost. 2000;26(3):305-11. Review.

PMID:
11011848
15.

A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.

Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.

J Thromb Thrombolysis. 2005 Jun;19(3):189-96.

PMID:
16082606
16.

Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.

Torres JD, Cardona H, Alvarez L, Cardona-Maya W, Castañeda SA, Quintero-Rivera F, Cadavid A, Bedoya G, Tobón L.

Am J Hematol. 2006 Dec;81(12):933-7.

17.

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.

Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR.

J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):629-35.

PMID:
12454577
18.

Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR G677A among 594 thrombotic Jordanian patients.

Eid SS, Shubeilat T.

Blood Coagul Fibrinolysis. 2005 Sep;16(6):417-21.

PMID:
16093732
19.

Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.

Thromb Haemost. 2001 Sep;86(3):809-16. Erratum in: Thromb Haemost 2001 Dec;86(6):1598.

PMID:
11583312
20.

Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence.

Simsek E, Yesilyurt A, Pinarli F, Eyerci N, Ulus AT.

Gene. 2014 Feb 15;536(1):171-6. doi: 10.1016/j.gene.2013.11.019. Epub 2013 Dec 12.

PMID:
24334115

Supplemental Content

Support Center